PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 15, 2026Trends in Neurosciences0 citationsOpen Access

A timeline of tau-mediated synaptotoxicity

View Full Paper
CBCalum BonthronCDClaire S. Durrant

Key Points

  • The aim is to understand how oligomeric tau contributes to synaptic impairments in Alzheimer's disease.
  • Analysis of tau-mediated synaptic deficits over time.
  • Investigating the impact of oligomeric tau on synaptic health.
  • Exploration of potential therapeutic strategies based on timeline insights.
  • Oligomeric tau was linked to increasing synaptic impairments at specific timelines.
  • Understanding tau's role may help in developing new treatments for synaptic loss.

Abstract

Oligomeric tau has been increasingly implicated in synaptic impairments observed in Alzheimer's disease. In a recent study, Pareja-Navarro and colleagues provide insights into the precise timeline of synaptic deficits induced by oligomeric forms of tau. Such knowledge could aid in the design of therapeutic interventions to prevent synaptic loss.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bonthron et al. (2026) studied this question.

synapsesocial.com/papers/69df2a4be4eeef8a2a6af76dhttps://doi.org/10.1016/j.tins.2026.03.011
Ask AI
Helpful
Bookmark
Share
View Full Paper